Previous Article | Next Article ![]()
Infection and Immunity, May 2002, p. 2256-2263, Vol. 70, No. 5
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.5.2256-2263.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Laboratoire des Mécanismes Moléculaires de la Pathogenèse Bactérienne, INSERM U447, Institut Pasteur de Lille, F-59019 Lille Cedex,1 Unité de Génetique Mycobactérienne, Institut Pasteur, F-75724 Paris Cedex, France,2 Department of Microbiology, Colorado State University, Fort Collins, Colorado 805233
Received 10 August 2001/ Returned for modification 8 October 2001/ Accepted 28 January 2002
|
|
|---|
|
|
|---|
In bacteria, two-component systems provide a conserved mechanism for the adaptive regulation of gene expression in response to a wide variety of environmental signals. These systems involve a histidine kinase sensor protein and a cognate response regulator, which classically controls transcription of target genes (20). They regulate important and diverse physiological or metabolic processes such as stress responses, nutrient utilization, quorum sensing, or cell division (12). Moreover, they frequently play a critical role in virulence, by coordinating expression of genes involved in pathogenesis (e.g., see reference 5). Some of them have been shown to be required for entry, survival, or multiplication inside host cells, such as for Salmonella spp. (e.g., see references 8, 14, and 15), Yersinia (19) and Brucella spp. (25).
The genome of M. tuberculosis has the potential to encode 11 complete two-component systems (1). Their function and the signals sensed by these systems are not known, and so far only four of them, MtrA-MtrB (Rv3246c-Rv3245c), SenX3-RegX3 (Rv0490-Rv0491), TrcS-TrcR (Rv1032c-1033c), and DevR-DevS (Rv3132c-3133c), have been partially characterized (2, 9, 11, 26, 28). Expression of the Mycobacterium bovis BCG mtrA gene has been shown to be upregulated in murine macrophages (4, 28). In contrast, in M. tuberculosis this gene is not regulated in macrophages and was found to be indispensable for this organism (30). Recently, the expression of another M. tuberculosis two-component system operon, designated prrA-prrB, was found, by selective capture of transcribed sequences, to be induced in human primary macrophages (7). However, the implication of these genes in intracellular growth of M. tuberculosis has not been elucidated up to now.
In an effort to study the function of M. tuberculosis two-component systems, we have screened an ordered transposon mutagenesis library (13) for mutants deficient in these systems. We describe here the identification of three mutants affected in the genes coding for Rv0491 (RegX3 response regulator), Rv0903c (PrrA response regulator), and Rv1032c (TrcS histidine kinase), respectively. The consequences of these mutations for survival and multiplication in murine macrophages were investigated, and the intracellular expression profiles of the corresponding genes were analyzed.
|
|
|---|
Identification of M. tuberculosis mutants deficient in two-component systems. The M. tuberculosis mutants were isolated by PCR screening of an ordered transposon mutagenesis library (13) as follows. PCR amplifications were carried out on a GenAmp PCR system 9600 (Perkin-Elmer), using the OP primer specific for the inverted repeats of IS1096 and directed outwards from the transposon (13) and primers 5'-CCTCGCGACTCGGTTGCAACGCT-3' (prrA up) or 5'-CGTGATGAGGGCGTCCTGGTCGTTC-3' (prrA down), 5'-CCTGGGTCGGACACGGCGTGTT-3' (trcR up) or 5'-GTCGTGCAGCACGGCAATGAGGTT-3' (trcR down), and 5'-GGGTGCTGGGCGACCAAACTCTG-3' (regX3 up) or 5'-CGGCGCCGACGAGCAGCTTT-3' (regX3 down) for prrB-prrA, trcS-trcR, and senX3-regX3, respectively. PCR fragments were purified by using the Geneclean II kit (Bio 101) and directly sequenced using an automated DNA sequencer (model 373; Applied Biosystems), a dye deoxy terminator cycle sequencing kit (Applied Biosystems) and the oligonucleotide prrA up, trcR down, or regX3 1465 (5'-GCAGGCGCGAGAGCCCGAAC-3').
DNA extraction and Southern blot analysis.
DNA was extracted from the mycobacteria as described previously (21), except that no D-cycloserine was added to the bacterial culture. After enzyme digestion of the DNA and electrophoresis under standard conditions, the agarose gels were incubated in 0.25 N HCl for 15 min, and Southern blotting was carried out overnight in 0.4 N NaOH, using positively charged nylon membranes (Boehringer). Membranes were rinsed four times in 6x SSC (0.9 M NaCl, 0.09 M C6H5Na3O7 · 2H2O, pH 7.0). The Megaprime random-primed labeling kit (Amersham) and 5 µCi of [
-32P]dCTP (6,000 mCi/mmol) were used to label probes. The entire Tn5368 transposon was isolated as an NcoI-NotI fragment from pPR32 (21) and used as the transposon probe. The senX3-regX3 probe was obtained as an EcoRI-BamHI fragment from pRegX3Bc1 (26), while the prrA and trcS probes were DNA fragments obtained by PCR using the pairs of oligonucleotides 5'-AAAAGATCTATGGGCGGCATGGACACTGGTGTGA-3' and 5'-AAAAAGCTTATTCTGCATACGCAGCACGAATCCGACT-3' and 5'-AAGGATCCGGAATCGTCGGGCACAC-3' and 5'-AAAAAGCTTCAGGCGGTAGTGGCGATCTGCTGC-3', respectively. Prehybridization and hybridization were carried out at 68°C using 6x SSC, 5x Denhardt's reagent (containing [per liter] 1 g of Ficoll Type 400, 1 g of polyvinylpyrrolidone, and 1 g of bovine serum albumin), 0.5% sodium dodecyl sulfate (SDS), and salmon sperm DNA (100 µg ml-1). Serial washes were performed under the following conditions: two washes in 2x SSC-0.5% SDS at room temperature for 5 min, two washes in 0.2x SSC-0.1% SDS at room temperature for 15 min, two washes in 0.2x SSC-0.1% SDS at 42°C for 15 min, and two washes in 0.1x SSC-0.1% SDS at 68°C for 15 min. X-Omat AR X-ray film (Kodak) was exposed overnight to the blots at -80°C.
Plasmid constructions. The prrB-prrA, trcR-trcS, and senX3-regX3 operons were amplified by PCR from M. tuberculosis Mt103 genomic DNA using the following pairs of oligonucleotides: 5'-GCTCTAGATGAGGTCAGGGCCGCAGGGCTAAC-3' and 5'-CCGCTCGAGGCTACCGCCGGATCGGGTTG-3', 5'-GGACTAGTCTCTCAGGCGGTAGTGGCGATCTG-3' and 5'-CCCACAACCTGGTCACGATCAG-3', and 5'-GGATCCAATTGTTTGAGATCCCACCTGC-3' and 5'-CTAGCCCTCGAGTTTGTAGCCCAG-3', respectively. The senX3-regX3 PCR product was digested with BamHI (the BamHI site is underlined) and cloned into the pBSh-D shuttle vector (22), previously digested with BamHI and EcoRV. This gave rise to pBSh-D-SRX3. The prrA-prrB and trcR-trcS products were first introduced into the EcoRV site of pZero-2 (Invitrogen). The resulting plasmids were then digested with NotI, blunt ended, and then digested with BamHI, and the inserts were cloned into pBSh-D, resulting in pBSh-D-902/3c and pBSh-D-1032/3c, respectively.
The 5' regions of prrA, trcR, and senX3 were amplified by PCR from pBSh-D-902/3c, pBSh-D-1032/3c, and pBSh-D-SRX3 using the following pairs of oligonucleotides: 5'-AAGGATCCTTACACCCGAGGTGAGGTCACAC-3' and 5'-AAAGATCTGCTACCGCCGGATCGGGTTG-3', 5'-TTGGATCCTCAGATGGCTTGCCGCGGACGTTGAC-3' and 5'-GAAGATCTCCCACAACCTGGTCACGATCAG-3', and 5'-AGATCTTTACGAGAACACAGTCACAAGGAA-3' and 5'-GGATCCTGGTGCGCGGTGGTACGTATC-3', respectively. These sequences included in-frame stop codons (italicized) and BamHI or BglII sites (underlined). The PCR products digested with BamHI or BglII were cloned into the BamHI and ScaI sites of pJFX2 (27), yielding pFluo1, pFluo2, and pFluo5, respectively. All constructs were verified by sequencing.
Preparation and infection of mouse bone marrow-derived macrophages. Bone marrow cells were prepared and infected as previously described (13), with minor modifications. Bone marrow cells were flushed from the femurs of 7- to 8-week-old BALB/c mice and suspended in Dulbecco modified Eagle medium (DMEM) with Glutamax II and a low glucose (1 g liter-1) concentration (Gibco BRL) and enriched with 10% heat-inactivated fetal calf serum (Gibco BRL) and macrophage colony-stimulating factor (10 ng ml-1; R&D Systems). For the infection assays, the macrophages were seeded in 24-well cell culture clusters (Techo Plastic Products) (2 x 105 cells per well in a 1-ml volume) and allowed to differentiate for 6 to 8 days. Aliquots (500 µl) of mycobacterial suspensions were centrifuged at 4,000 x g for 15 min and then resuspended in 500 µl of Sauton medium. Bacterial aggregates were sedimented by centrifugation at 20 x g for 10 min. The bacterial supernatant was recovered, and bacterial concentrations were adjusted to 2 x 104 bacteria ml-1 with DMEM. An aliquot of each M. tuberculosis suspension used to infect the macrophages was plated onto Middlebrook 7H10 agar to establish the number of live bacteria in the inoculum.
The infection assay was as follows. The culture medium of each macrophage-containing well was removed, and 1 ml of the mycobacterial suspension was added to obtain a multiplicity of infection (MOI) of 0.1:1. Control wells containing noninfected macrophages were filled with 1 ml of fresh culture medium. Infected and noninfected cultures were incubated at 37°C in a 5% CO2 atmosphere for 18 h. Infection was terminated by removing the overlying medium and washing each well three times with 1 ml of DMEM (Gibco BRL) before adding 1 ml of fresh culture medium per well. At days 1, 3, 6, and 9, the numbers of intracellular CFU were evaluated for four independent wells containing infected macrophages for each of the three mutant strains and the wild-type M. tuberculosis strains. For this purpose, macrophage monolayers were washed three times in DMEM buffer and then lysed in 200 µl of phosphate-buffered saline (PBS) containing 0.1% Triton X-100 (Sigma). Different dilutions of the lysates were plated onto 7H10, 7H10-kanamycin, or 7H10-hygromycin agar to perform counts of Mt103 and the mutant and complemented mutant strains. The experiment was carried out three times independently.
Mouse infection. For intravenous infection experiments, 8-week-old female BALB/c mice were infected in the thin-layer vein with 106 viable units of parental or mutant strains. At indicated times, mice were sacrificed, and individual lungs, liver, and spleen were removed and homogenized. Serial dilutions were plated onto 7H10 medium for colony counting. For aerosol infection, C57BL/6J mice purchased from The Jackson Laboratory (Bar Harbor, Maine) were maintained under specific-pathogen-free conditions on sterile bedding, with water and mouse chow administered ad libitum. Mice were infected using a Glas-Col (Terre Haute, Ind.) aerosol generator such that bacteria were deposited in the lungs of each animal. The numbers of viable bacteria in target organs were determined at various time points by plating serial dilutions of lung homogenates on nutrient Middlebrook 7H11 agar for colony counting. Mice were killed by CO2 asphyxiation, and the lungs were aseptically excised. Each of these organs was individually homogenized in physiological saline solution, and serial dilutions of the organ homogenate were plated on nutrient 7H11 agar. For all experiments, a determination of the infecting dose was performed on lungs of mice infected for 1 day.
Flow cytometry. Bone marrow-derived macrophages were prepared and infected as described above at an MOI of 1:1 by BCG containing pFluo1, pFluo2, pFluo5, pJFX2 (negative control), or pFXJ4 (positive control) grown in minimal Sauton medium. After 4 h of infection, extracellular bacteria were removed by washing three times with DMEM, and incubation was continued at 37°C under 5% CO2. At different time points after infection, the macrophages were washed three times with PBS and incubated with 50 µl of trypsin (2.5 g liter-1 [Gibco BRL]) at 37°C for 5 min. Cells were then resuspended in 200 µl of PBS and analyzed with a FACSCalibur (Becton Dickinson). The flow cytometer was calibrated to measure only the fluorescence of the infected macrophage cell population and not of the free bacilli, by using side and forward scatter parameters of a noninfected macrophage suspension as a standard reference. This reference cell suspension was also used to eliminate the effects of macrophage autofluorescence.
|
|
|---|
![]() ![]() View larger version (55K): [in a new window] |
FIG. 1. Identification by PCR of mutations in two-component system genes among an M. tuberculosis transposon mutagenesis library. (A) The genes mutated by Tn5367 insertion are shown together with flanking genes and chromosomal BamHI sites. Arrowheads labeled OP or regX3, prrA, and trcS up or down indicate the positions of the primers used for the PCR screening. IR and t designate the inverted repeats and the trp transcriptional terminator present in the transposon, respectively. The sequence of the Tn5367 insertion sites in the three mutants is indicated. (B) Southern blot analysis of the mutants. Genomic DNA was digested with BamHI and probed with fragments of the target genes (shown in Fig. 1A) or with the entire transposon. Arrows on the left indicate the positions of DNA size markers (sizes are expressed in kilobases). wt, wild type.
|
Survival and multiplication of Mt21D3, Mt25H7, and Mt36G4 within macrophages. Mutants Mt21D3, Mt25H7, and Mt36G4 and the parental strain Mt103 showed similar growth rates in Middlebrook 7H9 medium-OADC and in minimal synthetic Sauton medium, and none of the mutants exhibited an extended lag phase, even when stationary-phase cultures were resuspended in fresh medium (data not shown). To investigate the effects of the transposon insertions on intracellular multiplication of the three mutants, we compared their growth rates with that of the wild-type strain within mouse bone marrow-derived macrophages. As shown in Fig. 2, mutants Mt25H7 and Mt36G4 had intracellular growth rates similar to that of the wild-type strain Mt103. In contrast, in three independent experiments, Mt21D3 showed a significant impairment in growth during the first days of infection, reaching an approximately 10-fold difference in CFU at day 6 compared to Mt103. However, after this initial period, Mt21D3 recovered full growth capacity to reach plateau levels of CFU similar to that of the wild type at day 9. The experiment could not be continued beyond day 9, because the infected macrophages started to undergo extensive lysis, as evidenced by microscopic observations. By using a recently constructed single-copy shuttle vector (22), we introduced the wild-type prrA-prrB genes into Mt21D3. When bone marrow-derived macrophages were infected with the complemented strain, named Mt21D3F, the intracellular growth kinetics were essentially identical to that of Mt103 (Fig. 2), indicating that wild-type prrA-prrB fully complemented the 21D3 mutation. Quantitative analysis of the Mt21D3F colonies recovered from infected macrophages indicated that the complementing plasmid was stably maintained during intracellular multiplication (data not shown).
![]() View larger version (15K): [in a new window] |
FIG. 2. Growth of Mt21D3, Mt21D3F, Mt25H7, Mt36G4, and Mt103 in mouse bone marrow-derived macrophages. Macrophages were infected at an MOI of 0.1:1 with 104 CFU of Mt21D3 (open triangles), Mt21D3F (filled triangles), Mt25H7 (circles), Mt36G4 (diamonds), or Mt103 (squares). At days 1, 3, 6, and 9, intracellular bacteria were recovered and plated for counting. For each time point and each strain, results are expressed as means ± standard deviations (error bars) of CFU counts of quadruplicate wells.
|
![]() View larger version (17K): [in a new window] |
FIG. 3. Activity of the prrA, trcS, and senX3 promoters. Bone marrow-derived macrophages were infected at an MOI of 1:1 with BCG containing pFluo1 (prrA [filled triangles]), pFluo2 (trcS [filled circles]), pFluo5 (senX3 [filled diamonds]), pJFX2 (negative control [open squares]), or pFXJ4 (positive control [filled squares]). After 4 h and 1, 3, 6, 9, and 14 days, the mean fluorescence intensities of infected macrophages were analyzed as described in Materials and Methods. The relative fluorescence (representing means ± standard deviations [error bars] from four independent assays) is expressed as a percentage of the mean fluorescence at time zero (set at 100%) corresponding to recombinant BCG strains in minimal Sauton medium. The mean fluorescences at time zero were 38, 43, 119, 48, and 325 arbitrary units for BCG containing pFluo1, pFluo2, pFluo5, pJFX2, and pFXJ4, respectively.
|
Survival and multiplication of Mt21D3, Mt25H7, and Mt36G4 in mice. Finally, we investigated the consequences of the transposon insertions in the three M. tuberculosis mutants on their multiplication capacity within the lungs, by aerosol infection of BALB/c mice with 103 CFU of each of the three mutants or of Mt103. The mycobacterial loads of the lungs were analyzed up to 40 days after infection. As shown in Fig. 4, all three mutants showed growth kinetics similar to that of Mt103. Mutant Mt21D3 was further tested by infecting BALB/c mice intravenously with 106 CFU of Mt21D3 or Mt103. Analysis of the mycobacterial loads in the lungs, the spleen, and the liver revealed no difference in the growth rates in any of the organs between the mutant and the wild-type strain, up to 31 days after infection (Fig. 5).
![]() View larger version (15K): [in a new window] |
FIG. 4. Growth of Mt21D3, Mt25H7, Mt36G4, and Mt103 in the lungs of aerosol-infected C57BL/6J mice. For each time point and each strainMt21D3 (open circles), Mt25H7 (filled circles), Mt36G4 (diamonds), and Mt103 (squares)the results are expressed as means ± standard deviations (error bars) of CFU counts for at least three mice.
|
![]() View larger version (9K): [in a new window] |
FIG. 5. Growth of Mt21D3 and Mt103 in the lungs (upper panel), spleens (middle panel), and livers (lower panel) of BALB/c mice infected intravenously. For each time point and each strainMt21D3 (open triangles), Mt21D3F (filled triangles), and Mt103 (squares)results are expressed as means ± standard deviations (error bars) of CFU counts for at least three mice.
|
|
|
|---|
prrA and prrB located 14 nucleotides downstream probably belong to the same operon (1). The gene downstream of prrB, which codes for a putative membrane protein, is oriented in the opposite direction. The gene upstream of prrA, encoding a subunit of an acetyl coenzyme A carboxylase involved in lipid metabolism, is separated from prrA-prrB by 132 bp. In mutant Mt21D3, the transposon located 5 nucleotides upstream of the prrA ORF (Fig. 1A) presumably prevents transcription of the prrA-prrB operon, as a transcriptional terminator is present at the 3' end of the aph gene in the transposon (17). While Mt21D3 was unaffected in its in vitro growth, it was impaired in its intracellular multiplication capacity during the first days of mouse macrophage infection, reaching an approximately 10-fold difference in CFU at day 6 compared to the parent strain. This phenotype was completely reverted when the mutant was complemented with a wild-type prrA-prrB copy, which constitutes independent evidence for a functional defect of prrA-prrB in Mt21D3 and rules out a polar effect on downstream gene expression. Interestingly, after the initial days of infection, the mutant eventually recovered its growth capacity to reach a maximal level of infection similar to that of the wild-type strain. This indicates a transient effect of the mutation, which is overcome in later stages of infection. Concordant with this transient phenotype, expression of prrA was rapidly, but also transiently, induced during infection of macrophages, as evidenced by the use of a BCG strain containing a transcriptional prrA-gfp fusion. As the green fluorescent protein used in this study is a rather stable molecule, the lack of continued increase in fluorescence after the initial rapid induction suggests that prrA is expressed only shortly after infection and then rapidly switched off. These results are consistent with those obtained by Graham and Clark-Curtiss (7), who were able to isolate the prrA cDNA from M. tuberculosis phagocytosed by human macrophages but not from M. tuberculosis grown in broth culture. Altogether the results indicate that the two-component system encoded by prrA-prrB is involved specifically in an early step in intracellular multiplication of M. tuberculosis. Interestingly, such transient defects in intracellular multiplication have been recently reported for transposon mutants in various genes of another facultative intracellular pulmonary pathogen, Legionella pneumophila (6, 10). These mutants showed an initial lag in multiplication within macrophages but were also able to multiply as well as the wild-type strain after prolonged incubation. Taken together with these findings, the results described here suggest a rather complex course of macrophage infection by such pathogens, comprising different stages during which these bacteria use genes required in a timely fashion.
Transcription of other M. tuberculosis genes, such as those encoding sigma factors or proteins involved in cation transport or lipid and cell-wall metabolism or invasion, is also induced during the first days of human macrophage infection (7). One of these genes, encoding isocitrate lyase, has recently been shown to be required for persistence of M. tuberculosis in mice (18). The availability of the Mt21D3 mutant will now allow us to test whether induction upon phagocytosis of any of these genes is controlled by prrA-prrB.
Despite its growth defect in the early phase of macrophage infection ex vivo, mutant Mt21D3 was unaffected in its capacity to multiply in the organs of mice infected intravenously or by aerosol, compared to the wild-type strain. It is likely that the mouse model of acute infection used here is not sensitive enough to detect a role in the early phases of macrophage infection.
Unlike the expression of prrA-prrB, the expression of the genes encoding the two other two-component systems did not appear to be regulated within the macrophages, nor did their inactivation affect intracellular growth of M. tuberculosis within bone marrow-derived macrophages or in mice during the acute phase of infection. These results indicate that trcS-trcR and senX3-regX3 do not play a major role in the initial phases of infection in these models.
This work was supported by INSERM, Institut Pasteur de Lille, through a grant from the Ministère de l'Education Nationale, de la Recherche et de la Technologie and from the Indo-French Center for the Promotion of Advanced Research. F.E. holds a fellowship of the Région Nord-Pas-de-Calais. K.P. holds a fellowship of the Ministère de la Recherche. P.S. is a Chercheur du Centre National de Recherche Scientifique.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»